Drug Trial Radar · NCT04608630
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
Last checked: Nov 20, 2026Latest source record: Mar 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
450
Planned (sponsor's estimate)
Start
Jul 15, 2021
Primary completion
Feb 28, 2027
Study completion Feb 28, 2027
Sponsor
- Lead sponsor
- Australian and New Zealand Intensive Care Research CentreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 29, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Bone Zone trial is a prospective, multi-centre, double-blind, phase II, randomised controlled trial evaluating the effect of denosumab or zoledronic acid compared to placebo on change in bone mineral density over one year in women aged 50 years or older and men aged 70 years or older requiring admission to intensive care for greater than 24 hours. 450 women aged 50 years or older and men aged 70 years or older, admitted to intensive care for greater than 24 hours will be recruited into the study from participating study centres.
Conditions
- Critical Illness
- Osteoporosis
Interventions
Denosumab 60 MG/MLDrug
Patients allocated to the Denosumab arm will receive Denosumab 60mg in 1ml, administered via subcutaneous injection on Study Days 1 and 180.
Zoledronic Acid 5Mg/Bag 100Ml InjDrug
Patients allocated to the Zoledronic acid arm will receive Zoledronic acid 5mg in 100ml 0.9% Sodium Chloride or 5% Dextrose, administered via intravenous infusion over at least 15 minutes on Study Day 1.
Sodium Chloride 0.9% or 5% Dextrose IntravenousDrug
Patients allocated to the placebo arm and Denosumab arm will receive 0.9% Sodium Chloride or 5% Dextrose 100ml administered via intravenous infusion over at least 15 minutes on Day 1.
Sodium Chloride 0.9% InjectionDrug
Patients allocated to the placebo arm and Zoledronic acid arm will receive 0.9% Sodium Chloride 1ml administered via subcutaneous injection on Days 1 and Day 180
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualised change in femoral neck bone mineral density for the year after Intensive Care dischargeTime frame: 12 months
Locations
22 sites in 2 countries. Site status is shown where the registry gives one.
St Vincent's Health Sydney
Sydney, New South Wales, Australia · Recruiting
Prince of Wales Hospital
Sydney, New South Wales, Australia · Recruiting
Blacktown Hospital
Sydney, New South Wales, Australia · Recruiting
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia · Recruiting
Wollongong Hospital, Illawarra Shoalhaven Health
Wollongong, New South Wales, Australia · Recruiting
Sunshine Coast University Hospital
Birtinya, Queensland, Australia · Recruiting
The Wesley Hospital
Brisbane, Queensland, Australia · Recruiting
Gold Coast University Hospital
Southport, Queensland, Australia · Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia · Recruiting
Barwon Health, University Hospital Geelong
Geelong, Victoria, Australia · Recruiting
Alfred Health
Melbourne, Victoria, Australia · Completed
Western Health - Footscray Hospital
Melbourne, Victoria, Australia · Recruiting
Western Health - Sunshine Hospital
Melbourne, Victoria, Australia · Recruiting
Royal Melbourne Hospital
Melbourne, Victoria, Australia · Recruiting
St Vincents Hospital Melbourne
Melbourne, Victoria, Australia · Recruiting
Austin Health
Melbourne, Victoria, Australia · Completed
Eastern Health - Box Hill Hospital
Melbourne, Victoria, Australia · Recruiting
St John of God Hospital Subiaco
Perth, Western Australia, Australia · Recruiting
Fiona Stanley Hospital
Perth, Western Australia, Australia · Recruiting
St John of God Hospital Murdoch
Perth, Western Australia, Australia · Recruiting
Auckland City Hospital
Auckland, New Zealand · Recruiting
Wellington Regional Hospital
Wellington, New Zealand · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.